MeSH tree: D03.633.100.473.402.613
The golden road to pharmaceutical riches can quickly become a rocky wilderness trail. Chemical compounds that hit a target in the lab often fall short in human studies.
Dec 13, 2023
0
37
An off-duty Alaska Airlines pilot's alleged midair sabotage attempt of a Horizon Air flight from Seattle to San Francisco on Sunday—and the pilot's later admission that he had been depressed—highlights the major concerns ...
Oct 26, 2023
0
39
A therapy session with Patricia Brown starts like any other. She leads her clients into a peaceful, quiet room, draped in beige and generic, calming artwork.
Oct 17, 2023
1
77
In recent years, interest in psychedelics and their possible benefit in treating psychiatric illnesses has been revived. Expectations are high, especially in obsessive-compulsive disorder, where patients' therapeutic options ...
Oct 6, 2023
0
283
The human brain can change—but usually only slowly and with great effort, such as when learning a new sport or foreign language, or recovering from a stroke. Learning new skills correlates with changes in the brain, as evidenced ...
Oct 3, 2023
0
83
A new research result from the University of Southern Denmark opens the door to the possibility of using psilocybin, the active compound in mushrooms with psychedelic properties, as a therapeutic tool through microdosing.
Oct 3, 2023
0
238
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.
Sep 17, 2023
0
57
A new study is adding to evidence that the party drug "ecstasy" can boost the benefits of talk therapy for people suffering from post-traumatic stress disorder (PTSD).
Sep 14, 2023
1
80
A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions. However, many challenges remain in defining their clinical benefits and overcoming the complex regulatory ...
Sep 7, 2023
0
49
A collaboration between 34 researchers at 18 institutions has looked into the efficacy and safety of psilocybin in patients with major depressive disorder.
